medigraphic.com
ISSN 1561-3062 (Electronic)

2019, Number 1

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2019; 45 (1)

Management of pregnancy in patients with hereditary angioedema

Salazar TL

Language: Spanish
References: 26
Page: 147-163
PDF size: 301.90 Kb.


ABSTRACT

Hereditary angioedema is a rare autosomal dominant genetic disease that constitutes a primary immunodeficiency due to deficiency of the complement system. It is characterized by recurrent edema of the skin, mucous membranes and submucosal tissues, which can affect any part of the body, respiratory tract and digestive system. The most feared complication is edema of the upper respiratory tract, which can cause death by asphyxia. Abdominal pain can simulate acute abdomen. Trauma, stress, drugs or infections can trigger seizures. The diagnosis is based on the recognition of the clinical characteristics and the laboratory alterations as the presence of decreased C4 in serum and the absence or great reduction of the level or inhibitor function of C1. This disease is more severe in women because it varies with hormones, menstruation and pregnancy; and it is important for medical professionals to know what to do when a patient with this disease wishes to use contraceptives or is pregnant. Pregnancy is a special moment when the obstetrician's knowledge of this disease, its prophylactic and therapeutic management are vital because this entity does not respond to the usual treatment of allergic edema, considering there are contraindicated drugs during pregnancy. Its treatment of choice is the infusion of complement C1 Inhibitor factor. Fresh frozen plasma is an option to consider in case of short-term prophylaxis or acute attack.


REFERENCES

  1. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078-87.

  2. Machado AF, Thomaz JE, Neto HJC, Riedi CA, Rosário NA. Agiodema Hereditário: Uma Actualização. Revista Médica da UFPR. 2015;2(1):33-8.

  3. Lumry WR. Overview of Epidemiology, Pathophysiology, and Disease Progression in Hereditary Angioedema. Am J Managed Care. 2013;19:S103-10.

  4. Vives Toledo R, Sorlí Guerola JV, Sierra Santosa L, García Ribesa M. Angioedema hereditario. REV CLÍN MED FAM. 2015;8(1):62-5.

  5. Salas Alanís J, Ocampo Garza J, Ocampo Candiani J. Urgencias dermatológicas. Dermatol Rev Mex. 2015;59:26-38.

  6. Salas-Lozano NG, Meza-CardonaJ, González-Fernández C, Pineda-Figueroa L, de Ariño-Suárez M. Angioedema hereditario: causa rara de dolor abdominal. Cir. 2014[citado 30 de abril de 2018];82(5):563-6. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=4&sid=dc9298da-ccfd-4d6a-8

  7. Krizova A, Gardner T, Little D’A L, Fatal laryngeal angioedema: a case report and a workup of angioedema in a forensic setting. Forensic Sci Med Pathol. 2015;11:558–63.

  8. Navarro Ruiz A, Crespo Diz C, Poveda Andrés JL, Cebollero de Torre A. Algoritmo de diagnóstico y tratamiento del angioedema hereditario como herramienta para su manejo. Farm Hosp. 2013[citado 25 de abril de 2018];37(6):521-9. Disponible en: http://scielo.isciii.es/pdf/fh/v37n6/12articuloespecial02.pdf

  9. Álvarez Paneque O, Portelles Ferrero MM, Martínez Ramírez R, Pérez González A. Angioedema hereditario, una enfermedad de fácil confusión en su diagnóstico. Rev Cubana Hematología, Inmunología y Hemoterapia. 2016[citado 30 de abril de 2018];32(1). Disponible en: http://revhematologia.sld.cu/index.php/hih/article/view/367/227

  10. Salazar Torres L, Díaz Marín C, Quintana Gómez F. El Angioedema hereditario, una batalla por un diagnóstico certero. Revista Acta Medica del Centro. 2015[citado 28 de abril de 2018];9(4). Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/297

  11. Mac Ginnitie AJ. Pediatric hereditary angioedema. Pediatr Allergy Immunol. 2014;25:420–7.

  12. Ustariz García C R. Angioedema hereditario. Revista Cubana de Hematología, Inmunol y Hemote. 2016[citado 30 de abril de 2018];32(2):176-89. Disponible en: http://scielo.sld.cu/pdf/hih/v32n2/hih03216.pdf

  13. Miranda AR, Ue APF, Sabbag DV, Furlani WJ, Souza PK, Rotta O. Hereditary angioedema type III (estrogen-dependent): report of three cases and literature review. An Bras Dermatol. 2013[citado 30 de abril de 2018];88(4):578-84. Doi: http://dx.doi.org/10.1590/abd1806-4841.20131818

  14. Caballero T, Canabal J, Rivero-Paparoni D, Cabañas R. Management of hereditary angioedema in pregnant women: a review; International Journal of Women’s Health. 2014[citado 30 de abril de 2018];6:839–48. Disponible en: http://dx.doi.org/10.2147/IJWH.S46460

  15. Zuraw BL, Christiansen SC. How we manage persons with hereditary angioedema .British Journal of Hematology. 2016;173:831–43. doi: 10.1111/bjh.1405

  16. Di Marco P, Monografía: Angioedema hereditario, 2012. Argentina. [citado 24 de abril de 2018]. Disponible en: http://www.aaiba.org.ar/links/Monografias_Angioedema_DiMarco.pdf

  17. Salazar Torres L, Díaz Marín C, Quintana Gómez F. Angioedema Hereditario y embarazo, en Villa Clara, Cuba. Revista Latinoamericana de Perinatología. 2016;19(1).

  18. Zuraw BL, Banerji A, Bemstein JA. US Hereditary Angioedema Association Medical Advisory Board 2013. Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency. J Allergy Clin Imunol in Practice. 2013;1: 458-67.

  19. Riedl MA. Creating a comprehensive treatment plan for hereditary angioedema. Immunol Allergy Clin N Am. 2013[citado 30 de abril de 2018];33:471-85. PMID: 24176212. Disponible en: www.ncbi.nlm.nih.gov/pubmed/24176212

  20. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from Hereditary Angioedema International Working Group. Allergy. 2014;69:602-16.

  21. Malbrán A, Malbrán E, Menéndez A, Fernández Romero DS. Angioedema Hereditario. Tratamiento del ataque agudo en la Argentina. Medicina (B Aires). 2014[citado 30 de abril de 2018];74:198-200. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=5&sid=dc9298da-

  22. Salazar Torres L, Batista Hernández NE, López Ocampo LG, García Fernández C. Angioedema Hereditario y su manejo actual en nuestro medio. Revista Acta Médica del Centro. 2016;10(4).

  23. Maurer M, Aberer W, Bouillet L, Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE. 2013;8:e53773.

  24. Clavero FI, Uriarte AG, Medel GT, Setién PG. Uso profiláctico de icatibant en un caso de angioedema hereditario tipo III. Rev Española de Anestesiología Reanimación. 2014;61(7):375-81.

  25. Salazar Torres L, Díaz Marín C, Quintana Gómez F. El Angiodema Hereditario en Villa Clara. Revista Medi Centro. 2016;20(4).

  26. Salazar-Torres L, Quintana-Gómez F, Díaz- Marín C. Dolor abdominal por angioedema hereditario. Presentación de casos. Rev Cubana Hemato Inmunol Hemoter. 2018;33(Suplemento especial 36): Congreso Hematología 2017. [citado 30 de abril de 2018]. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/issue/view/28




2020     |     www.medigraphic.com